Alzheimer's drug trials plagued by lack of racial diversity

Under-representation of people of colour sparks concerns over the safety and efficacy of drugs in diverse populations. Under-representation of people of colour sparks concerns over the safety and efficacy of drugs in diverse populations.

Related Keywords

Irvine ,California ,United States ,Tokyo ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,Silver Spring ,Maryland ,New York ,Indiana ,University Of Southern California ,Amsterdam ,Noord Holland ,Netherlands ,Columbia University ,San Francisco ,Shobha Dhadda ,Eli Lilly ,Doris Molina Henry ,Los Angeles ,John Sims ,Gil Rabinovici ,Reisa Sperling ,Alzheimer Association International Conference ,Harvard University In Cambridge ,University Of California ,Drug Administration ,Association International Conference ,Southern California ,Joshua Grill ,Harvard University ,Jennifer Manly ,New York City ,